Ipca MMF-500 mg Tablet 15's belongs to a class of medications called immunosuppressants used to prevent the body from rejecting a transplanted organ, such as a kidney, heart, or liver.

Ipca MMF-500 mg Tablet 15's contains ‘Mycophenolate mofetil’, which works by suppressing the immune system, allowing the transplanted graft to avoid rejection.

The common side effects of Ipca MMF-500 mg Tablet 15's are diarrhoea, vomiting, nausea, and headache. Most of these side effects do not require medical attention and resolve gradually over time. However, consult your doctor if any of these side effects persist or worsen.

Do not take Ipca MMF-500 mg Tablet 15's if you are allergic to any of its ingredients, are pregnant, or breastfeeding. Avoid donating blood or sperm without informing your doctor. Please do not take any vaccinations as they may be less effective.

Ipca MMF-500 mg Tablet 15's is used in the prevention of organ transplant rejection. The detailed uses of Ipca MMF-500 mg Tablet 15's are as follows:

• Prevention of Organ Rejection: Ipca MMF-500 mg Tablet 15's is used along with other immunosuppressants (such as corticosteroids and cyclosporine) to prevent the body from rejecting transplanted organs like the kidney, heart, or liver.
• Steroid-Sparing Agent: In some cases, Mycophenolate is used in combination with or as an alternative to corticosteroids to reduce the long-term side effects of steroid treatment in autoimmune conditions.

• Ipca MMF-500 mg Tablet 15's should be taken on an empty stomach, at least 1 hour or 2 hours after a meal or as directed by the doctor.
• It is usually taken twice daily at the same time each day or as prescribed by your doctor.
• Swallow Ipca MMF-500 mg Tablet 15's as a whole with a glass of water.
• Do not crush, chew, break it.

• Ipca MMF-500 mg Tablet 15's contains Mycophenolate mofetil, an immunosuppressant used primarily in organ transplant recipients.
• It helps the body accept transplanted organs (like the kidney, heart, or liver) by suppressing immune responses.
• Ipca MMF-500 mg Tablet 15's inhibits the function of white blood cells (T and B lymphocytes), which are responsible for attacking transplanted organs.
• It enhances the long-term success of organ transplantation.
• Ipca MMF-500 mg Tablet 15's is often used along with other immunosuppressants like tacrolimus or cyclosporine for optimal effect.
• Preferred over long-term use of corticosteroids due to fewer chronic side effects.

• Do not take Ipca MMF-500 mg Tablet 15's if you are allergic to any of its ingredients.
• Ipca MMF-500 mg Tablet 15's must not be taken by women who are pregnant or who may become pregnant, as it may cause miscarriage or birth defects.
• Inform your doctor before taking Ipca MMF-500 mg Tablet 15's if you have a sign of infection such as a fever or sore throat, have any unexpected bruising or bleeding, have a history of digestive system problems such as a stomach ulcer, or have rare hereditary disorders such as Lesch-Nyhan or Kelley-Seegmiller syndrome (conditions caused by a deficiency of the enzyme hypoxanthine-guanine phosphoribosyl-transferase [HGPRT]).
• Limit your exposure to sunlight as Ipca MMF-500 mg Tablet 15's increases the risk of skin cancer.
• Do not donate blood while taking Ipca MMF-500 mg Tablet 15's and for at least 60 days after discontinuing the therapy.
• Call your doctor right away if you think you or your partner is pregnant or if you miss a menstrual period.
• Please do not take any vaccinations (live vaccines) as they will not be very effective.